Page 11 - பயன்படுத்தப்பட்டது உயிரியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Xenter, Inc Appoints Industry Leaders Robert S Langer, Elazer R Edelman, David J Bearss and Mark Stautberg to Board of Directors; Closes $12M Series A

Published: May 07, 2021 -Xenter’s Expanding Team of Industry Leaders Poised to Advance Device/Data/Drug Technologies for Interventional Medicine, Pharmaceutical Advancements and Digital Health- SALT LAKE CITY (BUSINESS WIRE) Xenter, Inc. (XenterMD.com), the world’s first start-up Device-Data-Drug healthcare technologies company, today announced the appointment of four additional industry leaders to its Board of Directors and the closing of a $12M Series A offering of preferred stock. The additional members are Robert S. Langer, an Institute Professor at MIT and the most cited engineer in history and 4th most cited individual in any field who has authored more than 1,500 scientific papers. He is also a co-founder and board member of Moderna.

Salt lake cityUnited statesUniversity of utahMassachusetts institute of technologyBrigham young universityRoberts langerSumitomo dainippon pharmaEdwardj poitrasDavidj bearssRobert langerMark stautbergRichardj linderElazer edelmanElazerr edelmanMorrisj karnovskyInterventionalcardiology digitalhealth

Health: Bald men are up to 2 5 TIMES more likely to suffer severe COVID-19, study warns

Experts noted that more men hospitalised with COVID have pattern baldness Researchers recruited 65 men who had contract a severe case of coronavirus They looked in part of a gene linked to baldness and male hormone sensitivity Men with 22 or more repeating DNA molecules were more at risk from COVID The findings may lead to novel therapies or treatments for the coronavirus

United statesUnited kingdomAndy gorenLidia rudnickaBruce willisEuropean academy of dermatologyBiology incUniversity of warsawBritish association of dermatologistsApplied biologyEuropean academySpring symposiumMedical universityBritish associationஒன்றுபட்டது மாநிலங்களில்ஒன்றுபட்டது கிஂக்டம்

Invizius Announces Successful Series A Financing to Develop Anti-Inflammatory Treatment for Haemodialysis

Share this article Share this article MOTHERWELL, Scotland, May 6, 2021 /PRNewswire/ Invizius Limited ( Invizius ), a biotechnology company developing treatments to suppress unwanted innate immune responses, today announces that it has closed Series A financing of £5.3 million. The financing was led by existing investors Mercia, Downing Ventures, Old College Capital, Scottish Enterprise, Solvay Ventures and new investors Calculus Capital and experienced life science entrepreneur and investor, Dr Jonathan Milner. Although already over-subscribed, the company s Series A remains open to other investors until June 2021. Invizius will use the financing to complete a First-in-Man safety study in 2022 of its H-Guard ® Priming Solution to reduce the life-threatening inflammatory effects of haemodialysis.

United statesFrance generalUnited kingdomCity ofJonathan milnerTony kouzaridesPeter mathiesonCandy herbertDavid cleevelyAxol bioscienceRichard boydLaurence hurstAndrea youngMercia fund managementOld college capitalEv business loans

5 Mai, 16 Uhr: Den Klimawandel stoppen - dieses Studium hilft dir dabei

5 Mai, 16 Uhr: Den Klimawandel stoppen - dieses Studium hilft dir dabei
mittelstandcafe.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mittelstandcafe.de Daily Mail and Mail on Sunday newspapers.

Researcha roleDegree program industrial engineeringInternational degree program technicalCollege bremenInternational degree program policy managementCourse workCollege bremen wednesdayDegree programsFuture themesClimate changeDegree programs electrical engineeringApplied biologyFocus energyOptional studyநிச்சயமாக வேலைபட்டம் ப்ரோக்ர்யாம்ஸ்

LAUTECH gets acting Vice Chancellor | Tribune Online

LAUTECH gets acting Vice Chancellor | Tribune Online
tribuneonlineng.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tribuneonlineng.com Daily Mail and Mail on Sunday newspapers.

Michael ologundeMojeed liasuSeyi makindeLekan fadeyiPlant physiology department of pureLadoke akintola university of technologySenate buildingCouncil chamberProfessor ayodeji omole ledLadoke akintola universityProfessor mojeed liasuVice chancellorRelations officerTribune onlineGovernor seyi makindeProfessor michael ologunde